Affiliation:
1. 1 Quilmes National University Laboratory of Molecular Oncology, Department of Science and Technology R. Saenz Pena 352, Bernal B1876BXD 4365-7100 Buenos Aires Argentina
Abstract
A case of feline multicentric lymphoma is reported in an 8-year-old male cat weighing 4.7 kg. At the time of the clinical consultation the animal presented weight loss, anorexia and generalised lymphadenomegaly. After careful clinical observation and a detailed laboratory workup, the diagnosis of small cleaved cell lymphoma was established. It was classified as a stage III b multicentric lymphoma. Chemotherapy was initiated according to a classical COP protocol to which atorvastatin was added. After 34 months, the cat continues to enjoy an excellent quality of life with no clinical or haematological signs of lymphoma. This is the first report in clinical veterinary medicine about a new effective adjuvant therapy in feline multicentric lymphoma. Further studies are needed to confirm that the addition of atorvastatin can provide a regular, safe and improved treatment in feline lymphoma cases.
Reference25 articles.
1. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton’s Lymphoma Ascites tumor in mice;Ajith T. A.;J. Exp. Ther. Oncol.,2008
2. Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours;Burke L. P.;Leuk. Lymphoma,2008
3. Statins and cancer risk. A meta-analysis;Dale K. M.;JAMA,2006
4. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study;Noyelle C.;Carcinogenesis,2001
5. The risk to humans from malignant disease of their pets: an unsettled issue;Essex M.;J. Am. Anim. Hosp. Assoc.,1976